Skopos Labs, Inc. Elanco Animal Health Inc Transaction History
Skopos Labs, Inc.
- $300 Million
- Q3 2024
A detailed history of Skopos Labs, Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Skopos Labs, Inc. holds 983 shares of ELAN stock, worth $11,854. This represents 0.0% of its overall portfolio holdings.
Number of Shares
983Holding current value
$11,854% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ELAN
# of Institutions
437Shares Held
473MCall Options Held
4.62MPut Options Held
753K-
Dodge & Cox San Francisco, CA83.3MShares$1 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA52.6MShares$634 Million0.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.9MShares$590 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$281 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A621.3MShares$257 Million11.09% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.72B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...